TGR-63

N/A

Report date: 2023/12/20 15:00:14
NME

Base Information

Drug NameTGR-63
Drug Alias NameTGR-63
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIGC Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesIGC Pharma IncJawaharlal Nehru Centre for Advanced Scientific Research
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A